Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Open Letter, Statement of Concern and Request for Retraction

Open Letter, Statement of Concern and Request for Retraction, re: Roman et al.
Jul 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now with p < 0.00000000001 from 104 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19ivm.org
Open letter signed by 40 physicians detailing errors and flaws in the Roman et al. meta analysis, and requesting retraction.
Open Letter et al., 3 Jul 2021, preprint, 40 authors.
This PaperIvermectinAll
MD Robert T Schooley, Dr Schooley
A systematic review and meta-analysis of randomized controlled trials" Clinical Infectious Diseases, ciab591 Accepted manuscript
Disclaimer: these indicate the personal opinions of the signatories and there is no intention to associate their institutions with them.
References
Dr, Anello, Italy, None
Dr, Banner, None
Dr, Bernstein, Family physician
Dr, Bsc, None
Dr, Ernesto De Bernardis, Md, Clinical Pharmacologist
Dr, Flores, None
Dr, Hamm, Bsc, Astmh, None
Dr, Hinton Mb Chb, Surgeon, None
Dr, Jones, Mbchb, None
Dr, Lacerda Almeida De, Dantas, Infectious Diseases Specialist
Dr, Mitchell Mbchb, None
Dr, Peers, Drcog, Dfsrh, Ffsrh, None
Dr, Phillips, Physician, None
Dr, Powell, None
Dr, Ralph, None
Dr, Scheim, None
Dr, Sheikh, Uk, None
Dr, Stephen Malthouse, Md, None
Dr, Veronica A Mcburnie, Md, Uk, None
Flavio, Cadegiani, Md, Msc, PI of the AndroCoV trials
Guimarães, Brazil, None
Liesel, Sotomayor, Md, Mrca, Uk, None
Manjul, Mbchb mrcp dtm+h, Consultant in Infectious Diseases and General Medicine
Marik, Fccp, Pulmonary and Critical Care Medicine
Nyjon, Eccles, None
Pinnel, Msc, Former CEO Clinical Research
Prof, Aldous, None
Prof, Babalola, Nigeria, None
Prof, Borody, Md, Australia, None
Prof, Carvallo, None, Professor of Internal Medicine
Prof, Gkioulekas, None
Prof, Howard, Tenenbaum, Perio, None
Prof, Stramezzi, Dds Phd, None
Prof, Yagisawa, None
Prof, Zwitter, Md, SLOVENIA
Shashikanth Manikappa, Mbbs, Md, Dnb, Fanzca et al., Specialis Cardiac Anaesthesia and Perioperative Medicine
Taylor, None
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit